[Rationale and current results of loco-regional chemotherapy in hepatic metastases of colorectal carcinoma].
Ficorella
C
C
Cagnazzo
P
P
Cardi
G
G
Ricciuti
F P
FP
Marchetti
P
P
Frati
L
L
Marchei
P
P
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002330:Carmustine / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D015179:Colorectal Neoplasms; D004317:Doxorubicin / Q000008:administration & dosage; D005467:Floxuridine / Q000008:administration & dosage; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007261:Infusions, Intra-Arterial / Q000295:instrumentation; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008727:Methotrexate / Q000008:administration & dosage; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D008954:Models, Biological; D011379:Prognosis
D000970:Antineoplastic Agents; D008937:Mitomycins; D005467:Floxuridine; D016685:Mitomycin; D004317:Doxorubicin; D002945:Cisplatin; D005472:Fluorouracil; D002330:Carmustine; D008727:Methotrexate
Razionale e risultati attuali della chemioterapia loco-regionale delle metastasi epatiche da carcinomi del colon-retto.